Moran Wealth Management »

Atrium Therapeutics shares owned by Moran Wealth Management

Quarter-by-quarter ownership of Atrium Therapeutics (RNA) shares owned by Moran Wealth Management from 13F filings

Historical chart of Moran Wealth Management investment in Atrium Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Atrium Therapeutics held by Moran Wealth Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Atrium Therapeutics by Moran Wealth Management

Quarter filed Position value Share count Share price at filing
2026-06-30 $448k 33k 13.45

More positions owned by Moran Wealth Management

Broadcom cs (AVGO)
Nvidia Corporation cs (NVDA)
Parker-Hannifin Corp cs (PH)
Trane Technologies cs (TT)
Lam Research Corp cs (LRCX)
Taiwan Semiconductor Mfg Ltd S ad (TSM)
Invesco S&p 500 Equal Weight Etf (RSP)
Caterpillar cs (CAT)
Howmet Aerospace cs (HWM)
Williams Sonoma cs (WSM)
Microsoft Corp cs (MSFT)
Cadence Design System cs (CDNS)
Eog Resources cs (EOG)
Applied Materials cs (AMAT)
Amphenol Corp Cl A cs (APH)

View all positions for Moran Wealth Management

Top funds holding Atrium Therapeutics

T. Rowe Price Associates
Sessa Capital IM
BlackRock
Susquehanna International
Vanguard Capital Management
CRCM
TIG Advisors
Geode Capital Management
Two Sigma Investments
Goldman Sachs Group
683 Capital Management
Fort Hoosac Management
State Street Corporation
Cantor Fitzgerald, L. P.
Slotnik Capital

View all funds holding Atrium Therapeutics